The ViiV Exchange is an online portal built by ViiV Healthcare to provide Australian healthcare professionals working in the HIV/AIDS sector with valuable product information, clinical data, information for patients and access to educational events and online webcasts.
To obtain access to the website, please register here. We encourage you to subscribe to email communications when you register to be informed about new content, updated product information and information on upcoming events.
About ViiV Healthcare
ViiV Healthcare is a global specialist HIV company dedicated to delivering advances in treatment and care for people living with HIV. We are an independent pharmaceutical company established in 2009, combining the power and expertise in the management of HIV from both GlaxoSmithKline (GSK) and Pfizer. Following a long-term collaboration on the joint development of several novel integrase inhibitors, we were joined by Shionogi in 2012.
Our company is 100% dedicated to HIV and we aim to take a deeper and broader interest in HIV/AIDS than any company has done before. Our focus is to deliver new and effective HIV medicines and to provide support for the communities affected by the epidemic.
Commitment to R&D in preventing and treating HIV
ViiV Healthcare’s current portfolio of HIV treatments provides us with the financial stability to take a sustainable, long-term view when investing in our pipeline of new medicines. Our scientists are 100% dedicated to finding new ways to limit the impact of HIV on the 37 million people living with the virus and understanding how best to prevent and treat the disease. Find out more about our commitment to R&D from the ViiV Healthcare global website.
Access to HIV treatment
With over 700 dedicated people located in 15 countries and three regional hubs, we extend this geographical reach still further via our relationship with GSK. We are equipped to move quickly in response to the needs of the HIV community and have launched industry-leading access initiatives to help deliver on WHO/UNAIDS goals to reach all those who need treatment. Globally, ViiV Healthcare has been actively involved in expanding access to treatment in resource poor settings through compassionate supply programs and royalty free licensing agreements. Find out more about our innovative and sustainable approach to access.
ViiV Healthcare in Australia
In Australia, ViiV Healthcare has been involved in supporting research through investigator initiated and pivotal clinical studies, and is actively involved in expanding access to treatment through compassionate supply.
We also actively support local community initiatives in HIV prevention, treatment and awareness.
Date of Preparation: July 2017 | AUS/HIV/0059/17